Inhalation Product Reference Selection is a methodological framework within regulatory pharmaceutics that systematically identifies and justifies a suitable reference listed drug for inhalation products based on physicochemical, biopharmaceutical, and clinical equivalence criteria to support generic product development and regulatory approval.
3
Publications
912
Citations
26
Authors
18
Institutions
Publications per year
2017–2026
1
Publications
3
1–3 of 3
Authors
26
- PN
1
h-index
- HC
1
h-index
- TV
1
h-index
- LH
1
h-index
- CF
1
h-index
1–5 of 26
Institutions
18
Sheffield Children's Hospital
Sheffield, United Kingdom
1 h-index
1 publications
802 citations
University of Huddersfield
Huddersfield, United Kingdom
1 h-index
1 publications
802 citations
Pulmonary Associates
Phoenix, United States
1 h-index
1 publications
802 citations
Institut Universitari d'Investigació en Atenció Primària Jordi Gol
Barcelona, Spain
1 h-index
2 publications
66 citations
Università degli Studi del Piemonte Orientale “Amedeo Avogadro”
Vercelli, Italy
1 h-index
1 publications
802 citations
Hôpital Bretonneau
Paris, France
1 h-index
1 publications
802 citations
The University of Western Australia
Perth, Australia
1 h-index
1 publications
802 citations
Erasmus University Rotterdam
Rotterdam, The Netherlands
1 h-index
1 publications
802 citations
1–8 of 18
Venues
- European Respiratory Journal
2 publications · 879 citations
2
h-index
- Drug Safety
1 publications · 33 citations
1
h-index
1–2